This funding round has closed
Medwise.ai organise the world's medical knowledge and empower every clinician to make the best decision for every patient. Partners include Novartis Biome UK.
135% of minimum goal raised
![]() |
Lead investor: SFC Capital |
Minimum Target £ 500,000 |
Minimum investment amount £ 10,000 |
Maximum Target £ 532,082 |
Maximum investment amount £ 50,000 |
Medwise.ai uses Artificial Intelligence to answer questions for clinicians faster than ever before. Currently, doctors cannot keep up with the latest research evidence, which means they can't provide the best care for their patients. Health care providers in the US are losing 3% of their revenue due to lack of adoption of evidence-based best practice, and in the UK this translates to the NHS losing £5bn every year. Medwise.ai utilises the latest transformer based neural networks and other Natural Language Processing technology to extract answers from multiple sources and support clinicians to make the best decisions for patients. The founders have experience at NHS, Google and Amazon.
Medwise.ai utilises the latest advancements in natural language processing technologies, including transformer-based neural networks, to instantly search and retrieve clinical answers from biomedical journal articles and clinical guidelines for clinicians. It provides quick, concise and relevant answers to clinicians. Unlike traditional search engines that provide you with a list of websites or documents, the product provides bite-sized, actionable and evidence-based answers extracted from trusted sources. Powered by AI, the product continues to improve as more user data is collected.
Currently, clinicians abandon 50% of their clinical questions due to time pressure and lack of good search tools. Without the right answers at the right time, not all patients receive the best practice care from their health care provider and could suffer from poor patient outcomes and increased downstream costs to the provider. Unwarranted variation in care costs the NHS £5 billion every year and costs the US healthcare system $105 billion every year. Medwise.ai utilise the latest advances in artificial intelligence software to help clinicians make better clinical decisions.
Medwise.ai partners with healthcare organisations and pharmaceutical companies to tailor our product for their needs and challenges around specific disease areas. The solution is sold through a B2B SaaS model and there is interest from 3 pharmaceutical companies, a telemedicine company and a NHS hospital to trial the solution.
Medwise.ai utilises the latest advancements in natural language processing technologies, including transformer-based neural networks, to instantly search and retrieve clinical answers from biomedical journal articles and clinical guidelines for clinicians. It provides quick, concise and relevant answers to clinicians. Unlike traditional search engines that provide you with a list of websites or documents, the product provides bite-sized, actionable and evidence-based answers extracted from trusted sources. Powered by AI, the product continues to improve as more user data is collected.
Currently, clinicians abandon 50% of their clinical questions due to time pressure and lack of good search tools. Without the right answers at the right time, not all patients receive the best practice care from their health care provider and could suffer from poor patient outcomes and increased downstream costs to the provider. Unwarranted variation in care costs the NHS £5 billion every year and costs the US healthcare system $105 billion every year. Medwise.ai utilise the latest advances in artificial intelligence software to help clinicians make better clinical decisions.
Medwise.ai partners with healthcare organisations and pharmaceutical companies to tailor our product for their needs and challenges around specific disease areas. The solution is sold through a B2B SaaS model and there is interest from 3 pharmaceutical companies, a telemedicine company and a NHS hospital to trial the solution.